openPR Logo
Press release

Human Milk Oligosaccharides Market by Application, Key Players (BASF SE, DuPont Nutrition & Health, Glycom), Brand Statistics, Gross Margin | Forecast

01-13-2022 01:06 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Market Research Future

Human Milk Oligosaccharides Market analysis

Human Milk Oligosaccharides Market analysis

Market Overview
The global human milk oligosaccharides market is poised to grow at 27.06% CAGR during the projection period. In addition, the market surpassed a valuation of USD 100 Mn in 2018. Human milk oligosaccharides (HMOs) are a type of sugar molecule derived from breast milk. In human breast milk, HMOs concentration is the highest after fats and carbohydrates.
Market scope of HMO is tremendous owing to increased sales of infant formula worldwide. HMOs are highly quality functional food, which are increasingly used in infant formula. Nonetheless, the expensive nature of the product and limited production capacity somewhat undermines the market potentials.
As consumers opt for healthier options, health-centric products gain further traction. More and more people are becoming aware about functional food, which is supporting the growth of the global human milk oligosaccharides market. Changing food habits coupled with the increased use of supplements and probiotics is likely to influence the market in the years ahead. Use HMOs in adult food is also viewed as a growing segment. Increased consumption of functional food and supplements worldwide is prompting manufacturers to focus on further food diversification and innovation. HMOs help in developing of the microbiota in the guts and prevention of harmful bacteria such as campylobacter and salmonella.
Global Human Milk Oligosaccharides Market:

Competition Analysis
Some of the top-notch companies discussed in MRFR’s report include BASF SE (Germany), DuPont Nutrition & Health (Denmark), Glycom (Denmark), Inbiose NV (Belgium), Medolac Laboratories (US), ZuChem (US), Abbott (US), Elicityl S.A. (France), Nestlé Health Science (Switzerland), Dextra Laboratories Limited (UK), Jennewein Biotechnologie GmbH (Germany) and Glycosyn LLC (US).

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7843

Global Human Milk Oligosaccharides Market: Segmental Analysis
The segmental analysis of the market has been conducted on the basis of application, type and region.

Based on application, the market has been segmented into laboratory research and food industry. Based on type, the market has been segmented into acidic and neutral. The neutral segment accounts for a significant share of the market in terms of value. The neutral segment is expected to witness a strong growth during the forecast period and surpass a valuation of USD 560 Mn.

Global Human Milk Oligosaccharides Market:
Regional Analysis
On the basis of region, the market has been segmented into North America, China, Europe and Japan. In terms of value, North America represents the largest market share. This market growth in the region can credited to the high demand for infant formula in countries such as the U.S. and Canada. Europe represent the second largest market for human milk oligosaccharides. The region is expected to maintain its position over 2025. Data released by UNICEF reveals that the U.K. has one of the lowest breastfeeding rates globally. Only 34% of all babies receive breast milk at six months old. This indicates towards high dependency on infant formulas. Moreover, approvals of various new HMO-based products in the regions is propelling the Europe HMO market. Japan holds a relatively lower market share owing to declining infant population in the county. In 2018, Japan commanded 3.26% market share in term of value.

Access Report @ https://www.marketresearchfuture.com/reports/human-milk-oligosaccharides-market-7843

Industry News
• Food Standards Australia New Zealand has reported announced that it is accepting application to approve two oligosaccharides that can be added to infant formula product.
DuPont Nutrition & Health (Copenhagen, Denmark) and Swiss multinational Lonza have reach an agreement, which will see the later manufacture and supply CARE4U 2’-FL, a human milk oligosaccharide (HMO). It is naturally-occurring in human milk and considered to improve digestive, cognitive and immune system in infants by improving the gut microbiota. This move is aligned with DuPont’s larger vision in excelling in microbiome segment.

Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013, United States of America

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Milk Oligosaccharides Market by Application, Key Players (BASF SE, DuPont Nutrition & Health, Glycom), Brand Statistics, Gross Margin | Forecast here

News-ID: 2526241 • Views: 178

More Releases from Market Research Future

Corporate Wellness Market Research Report, Industry Growth, Business Share, Size …
Market Highlights: The Global Corporate Wellness Market will reach value of USD 93.0 Billion in 2028 and is projected to grow at a CAGR of 7.0% over the forecast period. Corporate wellness programs are health promotion activities designed & conducted by corporate employers to support employees to understand their health risks, pursue healthy behavior at the workplace, and decrease the expenditure on healthcare. Currently, these programs are increasingly conducted by corporates
Facial Injectors Market Research Report, Industry Growth, Business Share, Size, …
Facial Injectors Market Information By Type (Dermal Fillers/Injectable Implants, Hyaluronic Acid, Synthetic Fillers, Collagen Fillers, Anti-Aging/Anti-Wrinkle Injections, Botulinum Toxin A, Poly-L-Lactic Acid (PLLA) Microparticles), By Application (Facial Line Correction Treatment, Face-Lift, Lip Treatments), By End-User (Dermatology Clinics & Cosmetic Centers, Hospitals), By Region (Americas, Europe, Asia Pacific and The Middle East & Africa) – till 2027 Market Scenario Market Research Future (MRFR) speculates that the Global Facial Injectors Market is predicted to
Healthcare Cold Chain Logistics Market Global Demand, Stock, Strategy, Size, Bus …
Healthcare Cold Chain Logistics Market Information by Product type (Biopharmaceuticals, Vaccines, Clinical Trial Materials and Others), Services (Storage, Transportation, Packaging and Others), Storage Techniques (Electrical refrigeration, Dry Ice, Gel Packs, Liquid nitrogen and Others), By Region (North America, Europe, Asia Pacific, The Middle East & Africa (MEA) and Latin America) – Global Forecast by 2027 Healthcare Cold Chain Logistics Market – Overview The progress in the pharmaceutical sector has amplified the reliance
Ophthalmic Drugs Market Research Report, Industry Growth, Business Share, Size, …
“Global Ophthalmic Drugs Market” Report of Market Research Future (MRFR)’s Explores Scope of the Study as Research Objective, Assumptions and Limitations in-depth. The report gives Market Dynamics by Major Drivers, Restraints, Opportunities and Challenges. Market Scenario A number of factors such as rising prevalence of eye diseases, growing awareness, huge research funding in ophthalmology, unmet medical needs, rising competition among market players, improving regulatory framework, aging population, and increasing government assistance, are

All 5 Releases


More Releases for HMO

Live Launch of JumboTiger (Coliving, HMO and Property Management Software)
JumboTiger is a full-stack real-time conversational property management software. It helps landlords/ owners, property managers, coliving & HMO operators to manage their rental portfolio. Lunch on - 16th Feb, 2021, 04:00PM GMT Register link for launch - https://zoom.us/webinar/register/WN_4B8oQpelR-KXFn17HdIyog What made you start your startup and what problem does it solve? We were running a successful bootstrapped coliving startup called [simplyguest.com] since 2015. We were growing at 10-15% m-o-m and had built a pretty successful business.
Human Milk Oligosaccharides (HMO) Global Market 2018: Key Players – Abbott, In …
Human Milk Oligosaccharides (HMO) Industry Description Wiseguyreports.Com Adds “Human Milk Oligosaccharides (HMO) -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database This report studies the global market size of Human Milk Oligosaccharides (HMO) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Milk Oligosaccharides (HMO) in these regions.  This research report
Human Milk Oligosaccharides (HMO) Market Share by Manufacturers, Revenue Status …
Global Human Milk Oligosaccharides (HMO) Market report explores and analyses the essential factors of market depending on present industry situations, market needs, business strategies and the growth condition. This report provides in depth study of “Human Milk Oligosaccharides (HMO) market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Human Milk Oligosaccharides (HMO) Market report also provides an in-depth survey of key players in the market which
Human Milk Oligosaccharides (HMO) Market Research Report 2017
Reports And Markets Publish a New Market Research Report On –"Human Milk Oligosaccharides (HMO) Market Research Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-human-milk-oligosaccharides-hmo-market-research-report-2017-1541215 In this report, the global Human Milk Oligosaccharides (HMO) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented
Global Human Milk Oligosaccharides (HMO) Market Research Report 2016
This report studies Human Milk Oligosaccharides (HMO) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Beghin Meiji (France) Beneo-Orafti SA (Belgium) Cargill, Inc. (US) Cosucra Groupe Warcoing SA (Belgium) Ingredion Incorporated (US) Royal Cosun (The Netherlands) Sensus (The Netherlands) Yakult Pharmaceutical Industry Co., Ltd. (Japan) Major Manufacturers of Prebiotic Food Products Abbott Nutrition (US) Clasado BioSciences
Human Milk Oligosaccharides (HMO) Market - Global Industry Analysis 2024
Human Milk Oligosaccharides (HMO) is a complex bioactive sugar molecule present in human milk. It functions as growth substrates for particular beneficial bacteria. Due to being structurally complex and diverse, extracting or synthesizing them for use in the formula is challenging. As human milk oligosaccharides (HMO) is beneficial for microbiome and immunity, therefore, many new techniques are getting researched and developed by the key player which include extracting HMO from